Literature DB >> 20944598

Epigenetic modifications and human disease.

Anna Portela1, Manel Esteller.   

Abstract

Epigenetics is one of the most rapidly expanding fields in biology. The recent characterization of a human DNA methylome at single nucleotide resolution, the discovery of the CpG island shores, the finding of new histone variants and modifications, and the unveiling of genome-wide nucleosome positioning maps highlight the accelerating speed of discovery over the past two years. Increasing interest in epigenetics has been accompanied by technological breakthroughs that now make it possible to undertake large-scale epigenomic studies. These allow the mapping of epigenetic marks, such as DNA methylation, histone modifications and nucleosome positioning, which are critical for regulating gene and noncoding RNA expression. In turn, we are learning how aberrant placement of these epigenetic marks and mutations in the epigenetic machinery is involved in disease. Thus, a comprehensive understanding of epigenetic mechanisms, their interactions and alterations in health and disease, has become a priority in biomedical research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20944598     DOI: 10.1038/nbt.1685

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  175 in total

1.  The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.

Authors:  Francois Fuks; Paul J Hurd; Daniel Wolf; Xinsheng Nan; Adrian P Bird; Tony Kouzarides
Journal:  J Biol Chem       Date:  2002-11-09       Impact factor: 5.157

Review 2.  X inactivation and the complexities of silencing a sex chromosome.

Authors:  Jennifer Chow; Edith Heard
Journal:  Curr Opin Cell Biol       Date:  2009-05-26       Impact factor: 8.382

3.  Histone modification levels are predictive for gene expression.

Authors:  Rosa Karlić; Ho-Ryun Chung; Julia Lasserre; Kristian Vlahovicek; Martin Vingron
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

4.  Histone H2B phosphorylation in mammalian apoptotic cells. An association with DNA fragmentation.

Authors:  K Ajiro
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

5.  Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.

Authors:  Shin-ichi Horike; Shutao Cai; Masaru Miyano; Jan-Fang Cheng; Terumi Kohwi-Shigematsu
Journal:  Nat Genet       Date:  2004-12-19       Impact factor: 38.330

6.  A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation.

Authors:  Daniela Kleine-Kohlbrecher; Jesper Christensen; Julien Vandamme; Iratxe Abarrategui; Mads Bak; Niels Tommerup; Xiaobing Shi; Or Gozani; Juri Rappsilber; Anna Elisabetta Salcini; Kristian Helin
Journal:  Mol Cell       Date:  2010-03-25       Impact factor: 17.970

Review 7.  The SWI/SNF complex and cancer.

Authors:  D Reisman; S Glaros; E A Thompson
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

8.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

Authors:  Ping Zhu; Elke Martin; Jörg Mengwasser; Peter Schlag; Klaus-Peter Janssen; Martin Göttlicher
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

10.  Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.

Authors:  Feng Miao; David D Smith; Lingxiao Zhang; Andrew Min; Wei Feng; Rama Natarajan
Journal:  Diabetes       Date:  2008-09-05       Impact factor: 9.461

View more
  913 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Druggability of methyl-lysine binding sites.

Authors:  C Santiago; K Nguyen; M Schapira
Journal:  J Comput Aided Mol Des       Date:  2011-12-07       Impact factor: 3.686

Review 3.  Statistical approaches for the analysis of DNA methylation microarray data.

Authors:  Kimberly D Siegmund
Journal:  Hum Genet       Date:  2011-04-26       Impact factor: 4.132

4.  Next-generation sequencing reveals regional differences of the α-synuclein methylation state independent of Lewy body disease.

Authors:  L de Boni; S Tierling; S Roeber; J Walter; A Giese; Hans A Kretzschmar
Journal:  Neuromolecular Med       Date:  2011-11-01       Impact factor: 3.843

Review 5.  Using DNA methylation to understand biological consequences of genetic variability.

Authors:  Dena G Hernandez; Andrew B Singleton
Journal:  Neurodegener Dis       Date:  2011-11-26       Impact factor: 2.977

Review 6.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

7.  IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data.

Authors:  Dan Wang; Li Yan; Qiang Hu; Lara E Sucheston; Michael J Higgins; Christine B Ambrosone; Candace S Johnson; Dominic J Smiraglia; Song Liu
Journal:  Bioinformatics       Date:  2012-01-16       Impact factor: 6.937

8.  Epigenetic change detection and pattern recognition via Bayesian hierarchical hidden Markov models.

Authors:  Xinlei Wang; Miao Zang; Guanghua Xiao
Journal:  Stat Med       Date:  2012-10-25       Impact factor: 2.373

9.  Epigenetic Therapy in Breast Cancer.

Authors:  Maryam B Lustberg; Bhuvaneswari Ramaswamy
Journal:  Curr Breast Cancer Rep       Date:  2011-03

10.  Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease.

Authors:  Y Tang; T Li; J Li; J Yang; H Liu; X J Zhang; W Le
Journal:  Cell Death Differ       Date:  2013-11-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.